Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Christofori

Showing results (71-80 of 133) with videos related to

Pageof 14
Sort By:
STAR Protocols|June 16, 2022
Tracking and characterization of partial and full epithelial-mesenchymal transition cells in a mouse model of metastatic breast cancerFabiana Lüönd, Natascha Santacroce, Christian Beisel, et al.
Oncotarget|December 2, 2015
The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progressionYu-Ting Huang, Qiang Lan, Lionel Ponsonnet, et al.
Molecular Cancer Research : MCR|May 8, 2012
Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinomaAdrian Zumsteg, Christoph Caviezel, Laura Pisarsky, et al.
Journal of Cell Science|February 21, 2014
Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transitionMaren Diepenbruck, Lorenz Waldmeier, Robert Ivanek, et al.
Life Science Alliance|November 25, 2021
Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switchingFabiana Lüönd, Martin Pirkl, Mizue Hisano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growthAndreas Wicki, Christoph Rochlitz, Annette Orleth, et al.
Plos One|March 2, 2013
Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8)Neha Tiwari, Nathalie Meyer-Schaller, Phil Arnold, et al.
Histochemistry and Cell Biology|October 24, 2003
Protein 4.1B in mouse islets of Langerhans and beta-cell tumorigenesisNobuo Terada, Nobuhiko Ohno, Hisashi Yamakawa, et al.
Seminars in Cancer Biology|March 1, 2012
Concepts of metastasis in flux: the stromal progression modelJonathan P Sleeman, Gerhard Christofori, Riccardo Fodde, et al.
Nature Communications|October 21, 2018
Mutational interactions define novel cancer subgroupsJack Kuipers, Thomas Thurnherr, Giusi Moffa, et al.
Pageof 14

Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
STAR Protocols|June 16, 2022
Tracking and characterization of partial and full epithelial-mesenchymal transition cells in a mouse model of metastatic breast cancerFabiana Lüönd, Natascha Santacroce, Christian Beisel, et al.
Oncotarget|December 2, 2015
The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progressionYu-Ting Huang, Qiang Lan, Lionel Ponsonnet, et al.
Molecular Cancer Research : MCR|May 8, 2012
Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinomaAdrian Zumsteg, Christoph Caviezel, Laura Pisarsky, et al.
Journal of Cell Science|February 21, 2014
Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transitionMaren Diepenbruck, Lorenz Waldmeier, Robert Ivanek, et al.
Life Science Alliance|November 25, 2021
Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switchingFabiana Lüönd, Martin Pirkl, Mizue Hisano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growthAndreas Wicki, Christoph Rochlitz, Annette Orleth, et al.
Plos One|March 2, 2013
Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8)Neha Tiwari, Nathalie Meyer-Schaller, Phil Arnold, et al.
Histochemistry and Cell Biology|October 24, 2003
Protein 4.1B in mouse islets of Langerhans and beta-cell tumorigenesisNobuo Terada, Nobuhiko Ohno, Hisashi Yamakawa, et al.
Seminars in Cancer Biology|March 1, 2012
Concepts of metastasis in flux: the stromal progression modelJonathan P Sleeman, Gerhard Christofori, Riccardo Fodde, et al.
Nature Communications|October 21, 2018
Mutational interactions define novel cancer subgroupsJack Kuipers, Thomas Thurnherr, Giusi Moffa, et al.
Pageof 14